Professor Emerita
Genesis of the Salk Institute: The Epic of Its Founders.
University of California Press, San Diego, 264 pp, 2013.
Charlotte DeCroes Jacobs. Jonas Salk: A Life
Isis, Journal of the History of Science Society, Vol. 107, No. 3, pp 683-684, 2016.
1. Wiame JM, and Bourgeois S.
Effect of citric acid on the growth of a variant of Bacillus subtilis.
Nature 172: 310-311, 1953.
2. Wiame JM, Storck R, and Bourgeois S.
The biosynthetic activity of transamination, studied with a variant of Bacillus subtilis.
Biochim. Biophys. Acta 10: 627-628, 1953.
3. Wiame JM, Storck R, and Bourgeois S.
La participation du cycle des acides tricarboxyliques au métabolisme azoté chez Bacillus subtilis.
Arch. Int'l. Physiol. 61: 431-432, 1953.
4. Wiame JM, Bourgeois S, and Lambion R.
Oxidative dissimilation of glycerol studied with variants of Bacillus subtilis.
Nature 174: 37-38, 1954.
5. Wiame JM, Bourgeois S, and Lambion R.
L'oxydation du gycérol étudiée à l'aide de variants de Bacillus subtilis.
Arch. Int'l. Physiol. 62: 155-156, 1954.
6. Wiame JM, and Bourgeois S.
Le rôle de l'anhydride carbonique dans les croissances bactériennes.
Biochim. Biophys. Acta 18: 269-278, 1955.
7. Wiame JM, and Bourgeois S.
L'assimilation de l'anhydride carbonique au cours de la croissance bactérienne.
Arch. Int'l. Physiol. Biochim. 63: 270, 1955
8. Wiame JM, Collette J, and Bourgeois S.
Etude de l'assimilation de l'ammonium à l'aide de variants de Bacillus subtilis.
Arch. Int'l. Physiol. Biochim. 63: 271, 1955.
9. Wiame JM, Rozenblum C, and Bourgeois S.
Contribution à l'étude du rôle biosynthétique du cycle des acides tricarboxyliques: Effet de l'acidité sur la croissance bactérienne (B. subtilis).
Biochim. Biophys. Acta 20: 43-47, 1956.
10. Vanderwinkel E, Bourgeois S, and Wiame JM.
L'oxydation de l'acide acétique par les granulations cytoplasmiques de Saccharomyces cerevisiae.
Arch. Int'l. Physiol. Biochim. 66: 129-130, 1958.
11. Bourgeois S, Wiame JM, and Lelouchier-Dagnelie H.
"Triauxie" of Proteus morganii in amino acids supplemented medium and its enzymatic interpretation.
Exp. Cell Res.18: 167-168, 1959.
12. Bourgeois S, Wiame JM, and Lelouchier-Dagnelie H.
Le "rétrocontrôle" de synthèses enzymatiques par la cystéine et ses dérivés au cours de la croissance de Proteus morganii.
Arch. Int'l. Physiol. Biochim. 67: 504-505, 1959.
13. Bourgeois S, Wiame JM, and Lelouchier-Dagnelie H.
Étude du "rétrocontrôle" de synthèses d'enzymes par des acides aminés au cours de la croissance de Proteus morganii.
Biochim. Biophys. Acta 38: 136-144, 1960.
14. Glansdorff N, Bourgeois S, and Wiame JM.
Interactions de la régulation enzymatique entre les biosynthèses de l'arginine et des pyrimidines chez Escherichia coli.
Arch. Int'l. Physiol. Biochim. 70: 149-151, 1962.
15. Tissières A, Bourgeois S, and Gros F.
Inhibition of RNA polymerase by RNA.
J. Mol. Biol. 7: 100-103, 1963.
16. Gros F, Dubert J-M, Bourgeois S, Michelson M, Soffer R, and Legault L.
Regulation of metabolic breakdown and synthesis of messenger RNA in bacteria.
Cold Spring Harbor Symposia on Quantitative Biology 28: 299-313, 1963.
17. Bourgeois S, Cohn M, and Orgel LE.
Suppression of and complementation among mutants of the regulatory gene of the lactose operon of Escherichia coli.
J. Mol. Biol. 14: 300-302, 1965.
18. Bourgeois, S.
Sur la nature du répresseur de l'Opéron Lactose d'Escherichia coli.
Thèse de Doctorat en Sciences.
Université de Paris, Paris, France, 1966.
19. Riggs AD, and Bourgeois S.
On the assay, isolation and characterization of the lac repressor.
J. Mol. Biol. 34: 361-364, 1968.
20. Riggs AD, Bourgeois S, Newby RF, and Cohn M.
DNA binding of the lac repressor.
J. Mol. Biol. 34: 365-368, 1968.
21. Riggs AD, and Bourgeois S.
On the lac-repressor-operator interaction and the purification of the lac operator.
Biophys. J. 9: A84, 1969.
22. Riggs AD, Suzuki H, and Bourgeois S.
Lac repressor-operator interaction. I. Equilibrium studies.
J. Mol. Biol. 48: 67-83, 1970.
23. Riggs AD, Newby RF, and Bourgeois S.
Lac repressor-operator interaction. II. Effect of galactosides and other ligands.
J. Mol. Biol. 51: 303-314, 1970.
24. Riggs AD, Bourgeois S, and Cohn M.
The lac repressor-operator interaction. III. Kinetic studies.
J. Mol. Biol. 53: 401-417, 1970.
25. Bourgeois S, and Riggs AD.
The lac repressor-operator interaction. IV. Assay and purification of operator DNA.
Biochem. Biophys. Res. Commun. 38: 348-354, 1970.
26. Bourgeois S, and Jobe A.
Superrepressors of the lac operon.
In: The Lactose Operon, JR Beckwith and DD Zipser, Eds., Cold Spring Harbor
Laboratory, Cold Spring Harbor, New York. pp. 325-341, 1970.
27. Bourgeois S, and Monod J.
In vitro studies of the lac operon regulatory system.
In: Ciba Foundation Symposium on Control Processes in Multicellular Organisms, GEW
Wolstenholme and J Knight, Eds., J & A Churchill, London, pp. 3-21, 1970.
28. Bourgeois S.
Techniques to assay repressors.
In: Methods in Enzymology, Volume XXI: Nucleic Acids Part D. L Grossman
and K Moldave, Eds., Academic Press, New York. pp. 491-500, 1971.
29. Bourgeois S.
The lac repressor.
In: Current Topics in Cellular Regulation, Vol. 4, BL Horecker and ER Stadtman, Eds.,
Academic Press, New York. pp. 39-75, 1971.
30. Jobe A, Riggs AD, and Bourgeois S
Lac repressor operator interaction. V. Characterization of super- and pseudo-wild-type repressors.
J. Mol. Biol. 64: 181-199, 1972.
31. Jobe A, and Bourgeois S.
Lac repressor-operator interaction, VI. The natural inducer of the lac operon.
J. Mol. Biol. 69: 397-408, 1972.
32. Jobe A, and Bourgeois S.
The lac repressor-operator interaction. VII. A repressor with unique binding properties:
the X86 repressor.
J. Mol. Biol. 72: 139-152, 1972.
33. Bourgeois S.
Methods for studying protein-nucleic acid interaction.
In: Karolinska Symposia on Research Methods in Reproductive Endocrinology, 5th Symposium - Gene Transcription in Reproductive Tissue, 1972. pp. 178-205.
34. Bourgeois S.
Methods for studying protein-nucleic acid interaction.
Acta Endocrinol. Suppl. 168: S178-S205, 1972.
35. Jobe A, and Bourgeois S.
Lac repressor-operator interaction. VIII. Lactose is an anti-inducer of the lac operon.
J. Mol. Biol. 75: 303-313, 1973.
36. Wang JC, Barkley MD, and Bourgeois S.
Measurements of unwinding of lac operator by repressor.
Nature 251: 247-249, 1974.
37. Jobe A, Sadler JR, and Bourgeois S.
Lac repressor-operator interaction. IX. The binding of Lac repressor to operators containing Oc mutations.
J. Mol. Biol. 85: 231-248, 1974.
38. Barkley MD, Riggs AD, Jobe A, and Bourgeois S.
Interaction of effecting ligands with lac repressor and repressor-operator complex.
Biochemistry 14: 1700-1712, 1975.
39. Bourgeois S, Barkley MD, Jobe A, Sadler JR, and Wang JC.
Effect of alterations in lac operator DNA on repressor binding.
In: Protein-Ligand Interactions. H Sund, G Blauer, Eds., WG de Gruyter & Co., Berlin, pp. 253-269, 1975.
40. Bourgeois S, and Pfahl M.
Repressors.
In: Advances in Protein Chemistry, Vol. 30. C.B. Anfinsen, and F.M. Richards, Eds.,
Academic Press, New York, pp. 1-99, 1976.
41. Pfahl M, and Bourgeois S.
Isolation of pseudorevertants of lac oc mutants: Selection system for superoperator mutations.
J. Bacteriology 128: 257-263, 1976.
42. Bourgeois S, and Newby RF.
Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines.
Cell 11: 423-430, 1977.
43. Barkley MD, and Bourgeois S.
The lac operon.
In: Symposium on Regulatory Biology. JC Copeland and GA Marzluf, Eds.,
Ohio University Press, Athens, Ohio. pp. 66-127, 1977.
44. Barkley MD, and Bourgeois S.
Repressor recognition of operator and effectors.
In: The Operon. JH Miller and WS Reznikoff, Eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. pp. 177-220, 1978.
45. Bourgeois S, Newby, RF, and Huet M.
Glucocorticoid resistance in murine lymphoma and thymoma lines.
Cancer Res. 38: 4279-4284, 1978.
46. Pfahl M, Sandros T, and Bourgeois S.
Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites.
Mol. Cell. Endocrinol. 10: 175-191, 1978.
47. Pfahl M, Kelleher RJ, and Bourgeois S.
General features of steroid resistance in lymphoid cell lines.
Mol. Cell. Endocrinol. 10: 193-207, 1978.
48. Bourgeois S, Jernigan RL, Szu SC, Kabat EA, and Wu TT.
Composite predictions of secondary structures of lac repressor.
Biopolymers 18: 2625-2643, 1979.
49. Bourgeois S.
Genetic analysis of glucocorticoid-induced lymphocytolysis.
In: Steroid Receptors and the Management of Cancer, Vol. II.
EB Thompson and ME Lippman, Eds., CRC Press Inc., Boca Raton, Florida, pp. 99-111, 1979.
50. Bourgeois S.
The somatic cell genetic approach to hormone action.
In: Steroid Receptors and the Management of Cancer, Vol. II.
EB Thompson and ME Lippman, Eds., CRC Press Inc., Boca Raton, Florida,
pp. 75-85, 1979.
51. Bourgeois S, and Newby R.
Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines.
Cancer Res. 39: 4749-4751, 1979.
52. Pfahl M, Gulde V, and Bourgeois S.
"Second" and "third operator" of the lac operon: An investigation of their role in the regulatory mechanism.
J. Mol. Biol. 127: 339-344, 1979.
53. Bourgeois S.
Genetic analysis of glucocorticoid action on lymphoid cell lines.
Proceedings of First International Congress on Hormones and Cancer, Rome, 1979.
54. Bourgeois S.
Glucocorticoid-induced lymphocytolysis: State of the genetic analysis.
J. Supramol. Structure 13: 401-410, 1980.
55. Bourgeois S.
Glucocorticoid-induced lymphocytolysis: State of the genetic analysis.
In: "ICN-UCLA Symposia on Molecular and Cellular Biology: Control of Cellular Division and Development". D Cunningham, E Goldwasser and J Watson, Eds. Alan R Liss, Inc.,
New York, Part B, pages 45-54, 1980.
56. Bourgeois S, and Newby RF.
Genetic analysis of glucocorticoid action on lymphoid cell lines.
In: Progress in Cancer Research and Therapy, Vol. 14: Hormones and Cancer.
S Iacobelli, R King, HR Lindner, and ME Lippman, Eds., Raven Press, New York.
pp. 67-77, 1980.
57. Pfahl M, and Bourgeois S.
Analysis of steroid resistance in lymphoid cell hybrids.
Somatic Cell Genetics 6: 63-74, 1980.
58. Bourgeois S.
Genetic analysis of glucocorticoid action on lymphoid cell lines.
In: Proceedings of Symposium on Hormones and Cancer: Basic Mechanisms and Clinical Applications. Worcester Foundation for Experimental Biology, Shrewsbury,
Massachusetts, 1980.
59. Bourgeois S.
Genetic analysis of steroid hormone action.
J. Supramol. Structure. Suppl 4:124, 1980.
60. Huet-Minkowski M, Gasson JC, and Bourgeois S.
Induction of glucocorticoid-resistant variants in a murine thymoma line by anti-tumor drugs.
Cancer Res. 41: 4540-4546, 1981.
61. Mermod J-J, Intrière L, MacLeod CL, and Bourgeois S.
Characterization of a new type of thymoma variants supersensitive to dexamethasone.
J. Steroid. Biochem. 15: 25-34, 1981.
62. Gasson JC, and Bourgeois S.
Genetic evidence for a function other than the receptor involved in the cytolytic response to dexamethasone
J. Cell Biol. 91: 210a, 1981.
63. Mermod J-J, Intrière L, MacLeod CL, and Bourgeois S.
Characterization of a new type of thymoma variants supersensitive to dexamethasone.
Proceedings of the Fifth International Symposium of the Journal of Steroid Biochemistry,
Puerto Vallarta, Mexico, 1981.
64. MacLeod CL, and Bourgeois S.
Analysis of the cell cycle phases in the response of murine thymoma cells to glucocorticoids.
J. Cell Biol. 91: 8a, 1981.
65. Gasson JC, and Bourgeois S.
Glucocorticoid induced increase in viral gp70 immunoreactive protein in a lymphoid cell line.
Fed. Proc. 40: 1871, 1981.
66. Huet-Minkowski M, Gasson JC, and Bourgeois S.
Glucocorticoid resistance in lymphoid cell lines.
In: Drug and Hormone Resistance in Neoplasia. Vol. 1, Chapter 4, N Bruchovsky and JH Goldie, Eds., CRC Press, Inc., Boca Raton, Florida. pp. 79-94. 1982.
67. Gasson JC, and Bourgeois S.
Genetic and epigenetic bases for glucocorticoid resistance.
ICN-UCLA Symposium on Evolution of Hormone-Receptor Systems, 1982
J. Cell. Biochem. Suppl 6: 156, 1982.
68. MacLeod DL, and Bourgeois S.
The response of murine thymoma cells to glucocorticoids: analysis of cell cycle phases.
UCLA Symposia on B and T Cell Tumors: Biological and Clinical Aspects, 1982.
J. Cell. Biochem. Suppl 6: 58, 1982.
69. Bourgeois S, and Gasson JC.
Genetic determinants of the glucocorticoid response in lymphoid cell lines.
ICN-UCLA Symposium on Rational Basis for Chemotherapy, Keystone, 1982.
J. Cell. Biochem. Suppl 6: 359, 1982.
70. Gasson JC, and Bourgeois S.
A new determinant of glucocorticoid sensitivity in lymphoid cell lines.
J. Cell Biol. 96: 409-415, 1983.
71. Bourgeois S.
DNA modifications and gene expression.
In: Gene Expression, UCLA Symposium on Molecular and Cellular Biology, New Series, Vol. VIII, DH Hamer and MJ Rosenberg, Eds., Alan R Liss, New York,
pp. 571-575, 1983.
72. Gasson JC, and Bourgeois S.
Determinants of glucocorticoid resistance in lymphoid cell lines.
In: Rational Basis for Chemotherapy: UCLA Symposium on Molecular and Cellular Biology. BA Chabner, Ed., Alan R. Liss, Inc., New York, pp. 153-176, 1983.
73. Gasson JC, Ryden T, and Bourgeois S.
Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line.
Nature 302: 621-623, 1983.
74. MacLeod CL, Hyman R, Bourgeois S, and Hays E.
Characterization of T-lymphoma cell lines: Differentiation and metastatic properties. In:
Leukemia Reviews International, Vol. 1. M. Rich and D. Yohn, Eds., Marcel Dekker, New York, pp. 192-193, 1983.
75. Bourgeois S, and Gilbert LI
Genetic and comparative aspects of steroid hormone receptors: Workshop Report.
In: Evolution of Hormone-Receptor Systems, UCLA Symposium on Molecular Cellular Biology, New Series, Vol 6, R Bradshaw, and GN Gill, Eds., Alan R. Liss, New York, pp. 471-476, 1983.
76. Oliver N, Newby RF, Furcht LT, and Bourgeois S.
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts.
Cell 33: 287-296, 1983.
77. Mermod J-J, Bourgeois S, Defer N, and Crépin M.
Demethylation and expression of murine mammary tumor proviruses in mouse thymoma cell lines.
Proc. Nat'l. Acad. Sci. USA, 80: 110-114, 1983.
78. Bourgeois S, Ryden T, and Gasson JC.
De novo DNA methylation inactivates the expression of glucocorticoid sensitivity in Tlymphoid cell lines.
J. Cell. Biochem. Suppl. 7a: 117, 1983.
79. MacLeod CL, Hyman R, Bourgeois S, and Hays E.
Differentiation of a T-lymphoma cell line in vitro.
J. Cell. Biochem. Suppl. 7b: 63, 1983.
80. Gruol DJ, Kemper ES, and Bourgeois S.
Measurements of the size of glucocorticoid receptors using radiation inactivation.
Biophys. J. 41: 199a, 1983.
81. MacLeod CL, Hays EF, Hyman R, and Bourgeois S.
A new murine model system for the in vitro development of thymoma cell heterogeneity.
Cancer Res. 44: 1784-1790, 1984.
82. Gruol DJ, Kempner ES, and Bourgeois S.
Characterization of the glucocorticoid receptor: Comparison of wild type and variant receptors.
J. Biol. Chem. 259: 4833-4839, 1984.
83. Bourgeois S, Pfahl M, and Baulieu E-E.
DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.
The EMBO Journal 3: 751-755, 1984
84. Koop AH, Hartley M, and Bourgeois S.
Analysis of the cya locus of Escherichia coli.
Gene 28: 133-146, 1984.
85. Gruol DJ, Dalton DK, and Bourgeois S.
Nuclear interactions of wild type and variant glucocorticoid receptors.
J. Steroid. Biochem. 20: 255-257, 1984.
86. Johnson DM, Newby RF, and Bourgeois S.
Membrane permeability as a determinant of dexamethasone resistance in murine thymoma cells.
Cancer Res. 44: 2435-2440, 1984.
87. Oliver N, Newby R, Furcht L, and Bourgeois S.
Fibronectin biosynthesis in a human fibrosarcoma cell line and adhesion variants.
J. Cell. Biochem. Suppl. 8b: 298, 1984.
88. Koop AH, Hartley M, and Bourgeois S.
Construction of single copy ampicillin resistant plasmids for cloning and promoter analysis.
Cold Spring Harbor Bacteriophage Meeting, 1984.
89. Bourgeois S.
Determinants of glucocorticoid sensitivity in T-lymphomas
Proceedings of the 23rd Midwinter Conference of Immunologists, 1984.
90. Gruol DJ, Dalton DK, and Bourgeois S.
Selection of variants cross resistant to dexamethasone and cAMP in a murine thymoma line.
Fed. Proc. 43: 1883, 1984.
91. Bourgeois S, and Gasson JC.
Genetic and epigenetic bases of glucocorticoid resistance in lymphoid cell lines.
In: Biochemical Actions of Hormones, XII, G. Litwack, Ed., Academic Press, New York, pp. 311-351, 1985.
92. Thompson EB, Smith JR, Bourgeois S, and Harmon JM.
Glucocorticoid receptors in human leukemias and related diseases.
Klinische Wochenschrift 63: 689-698, 1985.
93. Koop AH, Staprans SI, and Bourgeois S.
Specific binding of the cAMP receptor protein of Escherichia coli to the lactose operon promoter.
Biochimie 67: 161-175, 1985.
94. Gruol DJ, Campbell NF, and Bourgeois S.
Cyclic AMP increases the level of glucocorticoid hormone binding capacity in cAMPr variants of a murine thymoma.
J. Cell. Biol. 101: 353a, 1985.
95. Gruol DJ, Ashby MM, Campbell NF, and Bourgeois S.
Selection of variants in the regulation of glucocorticoid receptor function.
Fed. Proc. 44: 868, 1985.
96. Gruol DJ, Ashby MN, Campbell NF, and Bourgeois S.
Isolation of new types of dexamethasone-resistant variants from a cAMP-resistant lymphoma.
J. Steroid Biochem. 24: 255–258, 1986.
97. Gruol DJ, Campbell NF, and Bourgeois S.
Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function.
J. Biol. Chem. 261: 4909–4914, 1986.
98. Gruol DJ, Campbell NF, and Bourgeois S.
Cyclic AMP regulates glucocorticoid receptor function.
Fed. Proc. 45: 1898, 1986.
99. Bourgeois S, Crépin M, and Dean DC.
Glucocorticoid-induced responses in lymphoma and fibrosarcoma cell lines.
Growth Regulation of Cancer/Steroid Hormone Action Symposia,1986, Park City Utah.
100. Dean DC, Bowlus CL, and Bourgeois S.
Cloning and analysis of the promoter region of the human fibronectin gene.
Proc. Nat'l. Acad. Sci. USA, 84: 1876-1880, 1987.
101. Koop AH, Hartley ME, and Bourgeois S.
A low-copy-number vector utilizing beta-galactosidase for the analysis of gene control elements.
Gene 52: 245-256, 1987.
102. Gruol DJ, and Bourgeois S.
Role of cAMP-dependent protein kinase in glucocorticoid receptor function.
In: Recent Advances in Steroid Hormone Action, VK Moudgil, Ed., Walter de Gruyter &
Co, New York, pp. 315–335, 1987.
103. Gruol DJ, Campbell F, Rajah FM, and Bourgeois S.
Separation of nuclear and cytoplasmic forms of the glucocorticoid receptor by anion exchange chromatography.
Fed. Proc. 46: 2196, 1987.
104. Bourgeois S, Crépin M, and Dean DC.
Glucocorticoid-induced responses in lymphoma and fibrosarcoma cell lines.
J. Cell. Biochem. Suppl 11A: 100, 1987.
105. Dean DC, Newby RF, and Bourgeois S.
Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factorbeta and cAMP in human cell lines.
J. Cell Biol. 106: 2159-2170, 1988.
106. Gruol DJ, Campbell NF, and Bourgeois S.
High resolution anion exchange chromatography of the glucocorticoid receptor from WEHI-7 cells.
J. Steroid Biochem. 30: 287-290, 1988.
107 Rajah FM, Gruol DJ, and Bourgeois S.
Cyclic AMP-dependent protein kinase modulates the response to glucocorticoid hormone in the murine T-lymphoma cell line WEHI-7.
FASEB J. 2: 590a, 1988.
108. Gruol DJ, Harrigan MT, and Bourgeois S.
Modulation of glucocorticoid-Induced responses by cyclic AMP in lymphoid cell lines. In:
Gene Regulation by Steroid Hormones IV. AK Roy and JH Clark, Eds., Springer, New York,
NY. pp. 41-59, 1989.
109. Gruol DJ, Rajah FM, and Bourgeois S.
Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells.
Mol. Endocrinol. 3: 2119-2127, 1989.
110. Harrigan MT, Baughman G, Campbell NF, and Bourgeois S.
Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes.
Mol. Cell. Biol. 9: 3438-3446, 1989.
111. Dean DC, Blakeley MS, Newby RF, Ghazal P, Henninghausen L, and Bourgeois S.
Forskolin inducibility and tissue-specific expression of the fibronectin promoter.
Mol. Cell. Biol. 9: 1498-1506, 1989.
112. Gruol DJ, Rajah FM, and Bourgeois S.
Regulation of glucocorticoid receptor mRNA levels by cAMP and dexamethasone.
J. Cell Biology 107: 95a, 1989.
113. Harrigan MT, Campbell NF, and Bourgeois S.
Isolation and characterization of glucocorticoid-induced genes in T lymphocytes.
J. Cell Biology 107: 95a, 1989.
114. Baughman G, Harrigan MT, Campbell NF, Nurrish SJ, and Bourgeois S.
Genes newly identified as regulated by glucocorticoids in murine thymocytes.
Mol. Endocrinol. 5: 637-644, 1991.
115. Chandler LA, and Bourgeois S.
Post transcriptional down-regulation of fibronectin in N-ras-transformed cells.
Cell Growth Diff. 2: 379-384, 1991.
116. Harrigan MT, Campbell NF, and Bourgeois S.
Identification of a gene induced by glucocorticoids in murine T-cells: A potential G protein-coupled receptor.
Mol. Endocrinol. 5: 1331-1338, 1991.
117. Bourgeois S.
Cloning and identification of glucocorticoid-regulated genes in murine T-cells.
Endocrine Rev. 12: 20, 1991.
118. Baughman G, Lesley J, Trotter J, Hyman R, and Bourgeois S.
Tcl-30, a new T cell-specific gene expressed in immature glucocorticoid-sensitive thymocytes.
J. Immunol. 149: 1488-1496, 1992.
119 Bourgeois S., Gruol DJ, Newby RF, and Rajah FM
Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis.
Mol. Endocrinol. 7: 840-851, 1993.
120. Chandler LA, Ehretsmann CP, and Bourgeois S.
A novel mechanism of Ha-ras oncogene action: Regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.
Mol. Cell. Biol. 14: 3085-3093, 1994.
121. Gruol DJ, Zee MC, Trotter J, and Bourgeois S.
Reversal of multidrug resistance by RU 486.
Cancer Res. 54: 3088-3091, 1994.
122. Gruol DJ, and Bourgeois S.
Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid induced apoptosis.
Biochem. Cell Biol. 72: 561-571, 1994.
123. Gruol DJ, Zee MC, and Bourgeois S.
Evidence for glucocorticoid transport by the mouse MDR1 P-glycoprotein and inhibition of drug efflux by RU 486.
FASEB J. 8: A97, 1994.
124. Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, and Bourgeois S.
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
Mol. Cell. Biol. 15: 4395-4402, 1995.
125. Ehretsmann CP, Chandler LA, and Bourgeois S.
A nuclear post-transcriptional mechanism mediates the induction of fibronectin by glucocorticoids.
Mol. Cell. Endocrinol. 110:185-194, 1995.
126. Louahed J, Renaud J-C, Dermoulin J-B, Baughman G, Bourgeois S, Sugamura K, and Van Snick J.
Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines.
J. Immunol. 156: 3704-3710, 1996.
127. Gruol DJ, Vo QD, Bourgeois S.
A systematic selection of variants expressing mdr1 mutations affecting steroid transport.
Proc. Amer. Assoc. Cancer Res. 37: 326, 1996.
128. Gruol DJ, and Bourgeois S.
Development of glucocorticoid agonists capable of inhibiting p-glycoprotein function.
Proc. Amer. Assoc. Cancer Res. 37: 332, 1996.
129. Gruol DJ, and Bourgeois S.
Chemosensitizing steroids: Glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function.
Cancer Res. 54: 720-727, 1997.
130. Baughman G, Wiederrecht GJ, Chang F, Martin MM, and Bourgeois S.
Tissue distribution and abundance of human FKBP51, an FK506-binding protein that can mediate calcineurin inhibition.
Biochem. Biophys. Res. Comm. 232: 437-443, 1997.
131. Gruol DJ, Vo QD, and Bourgeois S.
The murine mdr1 P-glycoprotein, but not the mdr3 P-glycoprotein, can transport dexamethasone.
Proc. Amer. Assoc. Cancer Res. 38: 387, 1997.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
